Amarin Announces Notification of Patent Allowance for U.S. Application 13/610,217 Related to Vascepa(R) and FDA Approved MARINE Indication Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Notification of Patent Allowance for U.S. Application 13/610,217 Related to Vascepa(R) and FDA Approved MARINE Indication
Amarin Announces Notification of Patent Allowance for U.S. Application 13/284,408 Related to Vascepa(TM) and FDA Approved MARINE Indication Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Notification of Patent Allowance for U.S. Application 13/284,408 Related to Vascepa(TM) and FDA Approved MARINE Indication
Amarin Announces Notification of Patent Allowance for U.S. Application 13/349,150 Related to Vascepa(TM) and FDA Approved MARINE Indication Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Notification of Patent Allowance for U.S. Application 13/349,150 Related to Vascepa(TM) and FDA Approved MARINE Indication
Amarin Announces Issuance of U.S. Patents 8,793,727 and 8,293,728 for Vascepa(TM) Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Issuance of U.S. Patents 8,793,727 and 8,293,728 for Vascepa(TM)
Amarin Announces U.S. Patent 8,298,554 Issuance for Vascepa(TM) Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces U.S. Patent 8,298,554 Issuance for Vascepa(TM)
Amarin to Report Third Quarter 2012 Financial Results and Host Conference Call on November 8, 2012 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Report Third Quarter 2012 Financial Results and Host Conference Call on November 8, 2012
Amarin Reports Third Quarter 2012 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports Third Quarter 2012 Financial Results and Provides Update on Operations
Amarin Announces Notification of Patent Allowance for U.S. Application 13/608,775 Related to Vascepa® and FDA Approved MARINE Indication Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Notification of Patent Allowance for U.S. Application 13/608,775 Related to Vascepa® and FDA Approved MARINE Indication
Amarin Announces U.S. Patent 8,314,086 Issuance for Vascepa(R) Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces U.S. Patent 8,314,086 Issuance for Vascepa(R)
Amarin Announces Notification of Patent Allowance for U.S. Application 13/610,247 Related to Vascepa(R) and FDA Approved MARINE Indication Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Notification of Patent Allowance for U.S. Application 13/610,247 Related to Vascepa(R) and FDA Approved MARINE Indication
